Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1DSV
|
||||
| Drug Name |
benzyl (S)-1-((S)-2-(4-tert-butoxyphenyl)-1-cyanoethylamino)-4-methyl-1-oxopentan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL439156
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H35N3O4
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc2ccc(OC(C)(C)C)cc2)C#N
|
||||
| InChI |
InChI=1S/C27H35N3O4/c1-19(2)15-24(30-26(32)33-18-21-9-7-6-8-10-21)25(31)29-22(17-28)16-20-11-13-23(14-12-20)34-27(3,4)5/h6-14,19,22,24H,15-16,18H2,1-5H3,(H,29,31)(H,30,32)/t22-,24-/m0/s1
|
||||
| InChIKey |
JCLZMEGDTZWDMD-UPVQGACJSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.